AbbVie reports positive Phase II ovarian cancer trial data

1 year ago 108

AbbVie has reported positive data from the Phase II trial of mirvetuximab soravtansine in platinum-sensitive ovarian cancer (PSOC) patients.

1. Homepage
2. Cancer
3. AbbVie reports positive Phase II ovarian cancer trial data